The success of a bioanalytical ligand binding assay is significantly impacted by antibody quality. Using poorly characterized and controlled reagents can result in having to spend extra time reworking your assay or doing multiple validations, and can affect the translatability of data between phases.
Listen to this webinar to get insights into how to secure high quality, reproducible, and sustainable critical antibody reagents early in the development lifecycle, and avoid the frustrations and risks associated with assay development failure.
You will learn:
This webinar is recommended for scientists seeking custom antibody reagents designed to target a large molecule biologic or biosimilar, and suitable for the development of pharmacokinetic and anti-drug antibody ligand binding assays.
Presented by: Dr Paul Royle, Technical Sales Manager, Bio-Rad Laboratories
Paul Royle is the Technical Sales Manager for Bio-Rad’s Custom Antibody Service and has been with Bio-Rad’s antibody division for over 7 years. Prior to this, he worked in an immunology diagnostics company for almost 7 years. Paul holds a degree and PhD from the University of Nottingham (UK), and has post-doctoral research experience from the University of Warwick (UK).
Get more details about SpyTag technology, how it works with our antibody generation service, and see data for different experimental applications.